Interactive Transcript
0:00
Let's take a look at this lung cancer screening ct.
0:04
As we're scrolling through the lung prima,
0:06
we see some very mild upper lobe predominant central
0:09
lobular emphysema.
0:11
Little tiny holes scattered throughout the lungs
0:13
with no definable walls.
0:16
If a patient hasn't undergone pulmonary function testing
0:20
before, even if they're asymptomatic, uh,
0:22
pulmonary function testing is increasingly being recommended
0:25
for patients who have evidence of either emphysema
0:30
or airway centered small airway disease.
0:32
As a way to begin early treatments
0:35
and as we're scrolling through the lung parenchyma here
0:37
and the right lung, we're seeing an area
0:40
of brown glass opacity or a nonsolid nodule.
0:44
We can measure its size,
0:46
but it's gonna be well under
0:47
that 30 millimeter size threshold that we use in lung rants
0:51
to decide category two versus category three lesions.
0:54
And this one is about 10 millimeters,
0:58
so we keep scrolling down.
0:59
You can see there's a little bit of emphysema next to it
1:01
and sometimes emphysema can be really confounding when
1:05
you're looking at nodules.
1:07
Is it a cystic nodule?
1:09
Is this just a ground glass nodule next to
1:12
an area of emphysema?
1:14
In this case, this low density hole has no wall around it.
1:18
So I wouldn't call this a cyst within a ground glass nodule.
1:22
Just looks like a little bit of emphysema
1:24
that is sitting next to the ground glass nodule
1:26
or the nonsolid nodule.
1:27
So looking for a wall around that low density can help
1:31
and we continue to scroll
1:32
through the lung parenchyma looking
1:34
for other pulmonary nodules or evidence of lung disease.
1:40
Of course, we're gonna look at our soft tissue windows
1:42
and we see this patient has moderately severe corona
1:45
artery calcification.
1:46
Important to including the radiology reports
1:50
and make sure we do any risk factor assessment
1:52
for cardiovascular disease.
1:53
We can do things like measure the ascent.
1:56
ATA here looks a little bit generous and it certainly is.
1:58
It's 45 millimeters normal ascending ATA is up
2:02
to about 40 millimeters in most adults.
2:05
And so whenever we see a dilated ascent ATA 40 millimeters
2:09
or larger, um, we
2:11
will recommend a considering doing an echocardiogram
2:14
to evaluate for aortic valve function.
2:17
And we can also see some calcifications at the aortic root
2:20
that are in the region of the aortic valve.
2:21
And that's a sign this patient could be developing
2:25
calcific aortic stenosis.
2:28
So back to our soft tissue windows.
2:30
We've got this ground gloss nodule.
2:32
We wanna know is it new or has it grown from a prior exam.
2:38
So we're gonna look at some prior exams in this patient.
2:40
On the right we have an exam from three years earlier
2:45
and in the same area.
2:46
We're gonna be very careful to scroll
2:48
and map up the same area, looking for those areas
2:51
of emphysema and the other pulmonary vessels in the region
2:54
to make sure we're covering the same area
2:57
and it was not there
2:58
Three years earlier.
2:59
So it's a new nine to 10 millimeter ground glass nodule
3:04
or nonsolid nodule in the right upper lobe
3:07
for this approximately 10 millimeter ground glass nodule
3:10
that is new since a prior screening several years earlier.
3:14
This makes this a long RADS three category
3:17
for which the followup recommendation is
3:19
to do an interval followup CT using low dose
3:23
technique in six months.
3:25
This patient comes back for their CT a little bit early.
3:28
They came back the three month time point
3:30
and it has completely resolved.
3:32
So this new non-salary ground glass nodule almost likely
3:36
represent an area of focal infection or inflammation.
3:40
It has resolved. It is no longer
3:42
concerning for this patient.
3:43
And from this point on from the CT at left,
3:47
the recommendation would be to follow
3:49
with annual lung cancer screening in 12 months.
3:53
So new ground glass nodule confirm it was not there before.
3:56
Short-term interval followup has resolved.
3:59
We are no longer suspicious for um, an adenocarcinoma
4:03
and this patient goes back
4:04
to continuing their annual CT calendar
4:06
for lung cancer screening in 12 months.